TNF and metabolic dysfunction-associated steatotic liver disease: However, while previous studies have noted significantly lower incidence of NASH/NAFLD among those receiving anti-TNF alpha therapy [25], our study notes a protective effect against NASH, NAFLD, and IBD associated with ASA use among the bariatric surgery patient population.